Gene · 2266
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology. | Biomedicines | 2023 | 38255153 | PubTator, text mining | PubMed |
| Changes in DNA Methylation and mRNA Expression in Lung Tissue after Long-Term Supplementation with an Increased Dose of Cholecalciferol. | Int J Mol Sci | 2023 | 38203636 | PubTator, text mining | PubMed |
| Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 38201450 | PubTator, text mining | PubMed |
| The metaproteome of the gut microbiota in pediatric patients affected by COVID-19. | Front Cell Infect Microbiol | 2023 | 38188629 | PubTator, text mining | PubMed |
| [Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38185523 | PubTator, text mining | PubMed |
| Liquid biopsy in ovarian cancer in China and the world: current status and future perspectives. | Front Oncol | 2023 | 38169730 | PubTator, text mining | PubMed |
| Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis. | Biomedicines | 2023 | 38137330 | PubTator, text mining | PubMed |
| Proteomic analysis of glomeruli, tubules and renal interstitium in idiopathic membranous nephropathy (IMN): A statistically observational study. | Medicine (Baltimore) | 2023 | 38115247 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation. | Kidney Int Rep | 2023 | 38106579 | PubTator, text mining | PubMed |
| DAMPs and alarmin gene expression patterns in aging healthy and diseased mucosal tissues. | Front Oral Health | 2023 | 38098978 | PubTator, text mining | PubMed |
| Editorial: The role of minerals and trace elements in chronic diseases. | Front Cell Dev Biol | 2023 | 38078008 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Maternal Blood Plasma in Isolated Intrauterine Growth Restriction. | Int J Mol Sci | 2023 | 38069155 | PubTator, text mining | PubMed |
| Absence of Missense Variant Detection in Inherited Dysfibrinogenemia May Result from a Poor Raw Data Analysis Algorithm or Mosaicism. | Int J Mol Sci | 2023 | 38068874 | PubTator, text mining | PubMed |
| Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter. | Cancers (Basel) | 2023 | 38067351 | PubTator, text mining | PubMed |
| A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer. | Cells | 2023 | 38067168 | PubTator, text mining | PubMed |
| Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis. | Sci Rep | 2023 | 38040826 | PubTator, text mining | PubMed |
| SEMA4D/VEGF surface enhances endothelialization by diminished-glycolysis-mediated M2-like macrophage polarization. | Mater Today Bio | 2023 | 38024840 | PubTator, text mining | PubMed |
| A serious complication of high-power short-duration radiofrequency atrial fibrillation ablation associated with genetic hypodysfibrinogenemia. | HeartRhythm Case Rep | 2023 | 38023675 | PubTator, text mining | PubMed |
| Decellularized diseased tissues: current state-of-the-art and future directions. | MedComm (2020) | 2023 | 38020712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2266/papers?page=9